Is Harvard Bioscience Inc (NASDAQ:HBIO) A Better Buy Than Others After A -78.66% Fall In This Year?
In recent trading session, Harvard Bioscience Inc (NASDAQ:HBIO) saw 3.06 million shares changing hands at last check today with its beta currently measuring 1.54. Company’s